| DESCRIPTION OF ENHANCEMENTS |
Patch Description:
Corrective Action: The BCMA Print Label [PSBO BL] option was modified to
perform the drug validate process before the device selection process.
Therefore, the drug validation process will be performed if the system
device was set to BROWSER or queued to a device.
Problem: In reference to the BCMA Print Label [PSBO BL] option, a problem
was discovered in the coding logic that created an entry in the BCMA
Report Request file (#53.69). If the user canceled the label print
process as a result of a mismatch between the selected drug and patient,
an impartial or bogus entry would remain in the BCMA Report Request file
=================
(#53.69) occupying vital system resources.
Corrective Action: The BCMA Print Label [PSBO BL] option was modified by
inserting the necessary coding logic to delete the impartial or bogus
entry in the BCMA Report Request file (#53.69) when the print label
procedure is cancelled as a result of a mismatch between the selected
drug and patient.
Problem: In reference to the BCMA Print Label [PSBO BL] option, a problem
was discovered in the ScreenMan data input functions. If the selected
patient requires a Means Test, the option will abruptly display a message
to the user indicating "*** Patient Requires a Means Test ***" and the
ScreenMan data input process was rearranged out of order.
Corrective Action: The BCMA Print Label [PSBO BL] option was modified by
inserting the necessary coding logic to refresh the ScreenMan data input
screen when the Means Test notification message rearranged the data input
process. By refreshing the screen, the data input flow will return to
the next data input field.
Problem: In reference to the BCMA Print Label [PSBO BL] option, a problem
Problem: In reference to the BCMA Print Label [PSBO BL] option, a problem
was discovered in the coding logic used to set a variable that contained
the internal entry number of the selected drug. This problem was not
discovered in the initial release of BCMA V 2.0.
Corrective Action: The BCMA Print Label [PSBO BL] option was modified by
inserting the correct coding logic to extract and store the selected drug
internal entry number in the proper variable.
Problem: In reference to the BCMA Print Label [PSBO BL] option, a problem
was discovered in the drug validation process used to compare the
was discovered in the drug validation process used to check the patient
medication orders. The option only validated medication orders that were
classified a Unit Dose and it did not validate medication orders that
were classified as IV orders containing IV Additives and IV Solutions.
Corrective Action: The BCMA Print Label [PSBO BL] option was modified
by inserting the proper coding logic to validate IV orders that contained
IV Additives and IV Solutions.
selected drug with medication orders listed for the patient. The drug
validate process was performed only if the system device was set to
BROWSER or the user device.
|
